RAIMONDI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 8.775
NA - Nord America 7.409
AS - Asia 1.031
OC - Oceania 62
AF - Africa 55
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.352
Nazione #
US - Stati Uniti d'America 7.383
PL - Polonia 5.332
RU - Federazione Russa 1.349
IT - Italia 598
IE - Irlanda 454
SE - Svezia 401
SG - Singapore 303
HK - Hong Kong 224
CN - Cina 206
DE - Germania 167
UA - Ucraina 156
FI - Finlandia 108
VN - Vietnam 86
GB - Regno Unito 85
IN - India 71
AU - Australia 62
JO - Giordania 61
CH - Svizzera 49
ID - Indonesia 45
FR - Francia 27
CA - Canada 26
TR - Turchia 23
CI - Costa d'Avorio 22
ES - Italia 21
BE - Belgio 15
BR - Brasile 13
SC - Seychelles 12
ZA - Sudafrica 12
NL - Olanda 6
NG - Nigeria 4
AT - Austria 3
EU - Europa 3
MU - Mauritius 3
CO - Colombia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
NP - Nepal 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
HU - Ungheria 1
RS - Serbia 1
TW - Taiwan 1
Totale 17.352
Città #
Warsaw 5.331
Santa Clara 1.878
Fairfield 863
Chandler 481
Dublin 453
Woodbridge 382
Ashburn 380
Seattle 341
Cambridge 315
Houston 296
Wilmington 283
Jacksonville 235
Singapore 229
Ann Arbor 176
Princeton 129
Altamura 128
Hong Kong 127
Lawrence 127
Florence 110
Boardman 72
Dong Ket 68
Medford 67
Boston 65
Beijing 63
Mumbai 63
Melbourne 61
Brunswick 60
San Diego 52
Buffalo 50
Shanghai 50
Jakarta 45
Bern 40
Moscow 36
Phoenix 34
Munich 31
Falls Church 25
Dearborn 24
Abidjan 22
Kent 20
New York 18
Milan 17
Norwalk 17
Hillsboro 16
Izmir 16
Toronto 16
Brussels 14
Helsinki 14
London 14
Los Angeles 14
Barcelona 13
Naples 13
Rome 13
Cape Town 12
Auburn Hills 11
Bologna 11
Siena 10
Yubileyny 10
Andover 9
Ottawa 9
Alghero 8
Fort Wayne 8
Napoli 8
West Jordan 8
Livorno 7
Tappahannock 7
Redmond 6
Castelliri 5
Frankfurt Am Main 5
Marino 5
Verona 5
Dübendorf 4
Genova 4
Guangzhou 4
Kazan' 4
Lagos 4
Las Rozas de Madrid 4
Messina 4
Ningbo 4
Pune 4
Redwood City 4
Barga 3
Bari 3
Bresso 3
Fano 3
Hangzhou 3
Hefei 3
Irbid 3
Polignano a Mare 3
Saint Petersburg 3
Salerno 3
San Mateo 3
Strasbourg 3
Torre Del Greco 3
Vienna 3
Al Qāhirah al Jadīdah 2
Allschwil 2
Brentonico 2
Böblingen 2
Capannori 2
Casalecchio di Reno 2
Totale 13.645
Nome #
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 315
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 297
3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice 285
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 281
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 278
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 277
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 275
Monoamine oxidase is over-activated in left and right ventricles from ischemic hearts: an intriguing therapeutic target. 274
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes. 273
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 273
Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. 269
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists. 261
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 260
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 257
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. 253
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. 247
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 246
Isolation and pharmacological activities of the Tecoma stans alkaloids. 245
Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. 244
3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors. 244
Franca Buffoni (1924-2011): a pioneer in biochemical pharmacology 242
THE REDUCTION OF FOOD INTAKE INDUCED IN MICE BY BENZYLAMINE AND ITS DERIVATIVES 236
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 236
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats 236
Methylamine: a new endogenous modulator of neuron firing? 234
Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study 232
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 231
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats 230
3-iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mouse 229
The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice. 227
Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells. 217
Lipid peroxidation and cyclooxygenase-2 activity in human hepatocellular carcinoma cell lines with and without multiple drug resistance: correlation with cell growth 215
3-iodothyronamine, a new chapter in thyroid story: implications in learning processes 214
oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and post-ischemic myocardial injury 213
Losartan ameliorates diabetic vascular hyper-reactivity to angiotensin II by reducing ROCK1 expression and activity 213
Farmaci attivi sull'omeostasi glucidica 212
Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat. 210
The control of MAO activity, a resource underscored by the pharmacology 204
Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism 202
The sodium-dependent glucose transporters (SGLT) as a new promising pharmacological target in human ischaemic hearts 196
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 190
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 189
Pharmacological applications of copper amine oxidase inhibitors 184
null 171
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 167
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 157
Losartan reduces oxidative damage to renal DNA and conserves plasma antioxidant capacity in diabetic rats. 147
Which is the main molecular target responsible for the cardiovascular benefits in the empa-reg outcome trial? A journey through the kidney, the heart and other interesting places 146
Some histamine-related compounds interacting with the benzylamine oxidizing activity of rat white adipocytes. 141
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 141
Analoghi del glucagon-like peptide (GLP-1) per uso topico 134
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study 132
Reaction of pig plasma benzylamine oxidase with beta-aminopropionitrile. 132
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 128
Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats 126
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure 126
Pyridoxamine as inhibitor of the blood plasma benzylamine oxidase and other copper-containing amine oxidases. 126
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 126
Skin wound healing: some biochemical parameters in guinea-pig. 125
Hydrogen peroxide generation by monoamine oxidases in rat white adipocytes: role on cAMP production 125
Calcium modulatory properties of 2,6-dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations. 125
The effect of losartan treatment on the response of diabetic cardiomyocytes to ATP depletion 124
Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. 123
Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat adipocytes 123
Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications 123
Endogenous substrates of the semicarbazide-sensitive amine oxidase increased nitric oxide production in rat white adipocytes 122
The critical role of the proximal calcium ion in the structural properties of horseradish peroxidase 121
The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity. 119
Copper-dependent amine oxidases in angiogenesis induced by prostaglandin E1 (PGE1). 114
Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics. 113
Lipid and protein oxidation products,antioxidant status and vascular complications in poorly controlled type 2 diabetes 112
Activity and expression of semicarbazide-sensitive amine oxidase in a rodent model of diabetes: interactive effects with methylamine and alpha-amino guanidine 112
Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype. 110
Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. 107
Benzylamine-related compounds stimulate rat was deferens neurotransmission and potentiate memory in the mouse acting as potassium potassium channel blockers. 105
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 105
SEDUM TELEPHIUM L. POLYSACCHARIDES CONTENT AFFECTS MRC% CELL ADHESION TO LAMININ AND FIBRONECTIN 101
The multiple drug resistence phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. 99
Commentary: Euthyroid Sick Syndrome in Patients With COVID-19 99
The polysaccharide from Tamarindus indica (TS-polysaccharide) protects cultured corneal-derived cells (SIRC cells) from ultraviolet rays. 98
Protection against ultraviolet B-induced oxidative DNA damage in rabbit corneal-derived cells (SIRC) by 4-coumaric acid. 97
Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). 97
Restoration of Cardiomyocyte Functional Properties byAngiotensin II Receptor Blockade in Diabetic Rats 95
Hypofunctionality of Gi proteins as aetiopathogenetic mechanism for migraine and cluster headache. 95
Effect of xyloglucan Tamarind seed polysaccharide) on conjunctival cell adhesion to laminin and on corneal epithelium wound healing. 94
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 90
Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1) 87
Chronic treatment with omega3-PUFA decreases plasma concentration of asymmetric dimethyl arginine (ADMA) in aged spontaneously hypertensive rat (SHR). 86
Possible different fates for the hydrogen peroxide produced by rat white adipocyte amine oxidases 82
Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications 81
Activity and expression of semicarbazide-sensitive benzylamine oxidase in a rodent model of diabetes: interactive effects with methylamine and alpha-aminoguanidine. 79
New insight into the roles of the structural Ca2+ ions of horseradish peroxidase 79
Rhein and derivates. In vitro studies on their capacity to inhibit certain proteases. 78
The effect of losartan on expression of beta-adrenoceptors in cardiomyocytes of diabetic and normoglycemic rats 77
n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats. 77
Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling 76
Monoamine oxidase activity in end-stage heart failure associated with dilated and ischemic cardiomyopathies: a comparison between left and right ventricles 76
DM232 and DM235, two potent cognition-enhancers, increase NO levels in rat adipocytes 76
Prolonged N-3PUFA dietary supplementation improves fatty liver in patients with NAFLD 74
Asymmetric dimethyl arginine (ADMA), homocysteine and semicarbazide-sensitive amine oxidase activity (SSAO): new markers of oxidative stress in acute coronary syndromes 73
Totale 16.620
Categoria #
all - tutte 38.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.478 0 0 0 0 0 0 287 394 266 192 296 43
2020/20212.082 182 246 82 242 118 218 126 173 167 311 63 154
2021/2022798 26 83 44 34 33 31 34 58 44 59 131 221
2022/20232.128 196 368 123 136 160 369 285 119 244 11 58 59
2023/2024720 26 81 128 38 48 85 39 136 21 29 52 37
2024/20254.275 158 538 351 796 1.684 742 6 0 0 0 0 0
Totale 17.520